Objective: The objective of the present work is to develop a bi-layer tablet consisting of an Immediate Pulse Release [IPR] layer and a sustained release [SR] layer that can produce a distinct biphasic release having two different drug release rates. The IPR layer is intended to release a fraction of the dose rapidly at a faster rate and the SR layer is meant for slow release of the remaining dose at a slower rate for a desired period of time.Methods: The quantitative determination was carried out by UV spectrophotometer. Solid dispersion was prepared by melt method. IPR layer was prepared by direct compression method, SR layer was prepared by wet granulation method. In-vitro drug release study from tablets was carried out in USP II tablet ...
Objective: In the present research work, the aim was to prepare the bilayer tablet of atenolol for b...
Bilayer tablet is new novel of tablet for the successful development of controlled release formulati...
Point of present examination work was attempted to figure bilayer tablets of lornoxicam through its ...
AbstractObjective:The aim of present study is to formulate glipizide sustained release (SR) and imme...
Objective: The purpose of this study was to develop and evaluate bi-layer tablets for the immed...
Objective: The present study was to formulate and evaluate of sustained release bilayer tablets of a...
Hypertension or high blood pressure occurs when the high cardiac output exerts pressure on the arter...
Objective: The main objective of the present investigation is to develop a sustained-release (SR) fo...
The present work involves the formulation development, optimization and In-vitro evaluation of bila...
ABSTRACT Over the past 30 years, the expenses and complications involved in marketing new drug enti...
To get advantage of novel drug delivery in treatment of diabetes mellitus is centered aim of this wo...
The objective of present investigation is to design and characterise sustained release Simvastatin a...
The purpose of this study was to formulate and characterize bi-layer tablet of doxycycline immediate...
The aim of the work is to develop Bi-layered matrix tablets containing a Biguanide (API I) in SR la...
Objective: The objective of this research was to formulate bi-layer tablet which contains immediate-...
Objective: In the present research work, the aim was to prepare the bilayer tablet of atenolol for b...
Bilayer tablet is new novel of tablet for the successful development of controlled release formulati...
Point of present examination work was attempted to figure bilayer tablets of lornoxicam through its ...
AbstractObjective:The aim of present study is to formulate glipizide sustained release (SR) and imme...
Objective: The purpose of this study was to develop and evaluate bi-layer tablets for the immed...
Objective: The present study was to formulate and evaluate of sustained release bilayer tablets of a...
Hypertension or high blood pressure occurs when the high cardiac output exerts pressure on the arter...
Objective: The main objective of the present investigation is to develop a sustained-release (SR) fo...
The present work involves the formulation development, optimization and In-vitro evaluation of bila...
ABSTRACT Over the past 30 years, the expenses and complications involved in marketing new drug enti...
To get advantage of novel drug delivery in treatment of diabetes mellitus is centered aim of this wo...
The objective of present investigation is to design and characterise sustained release Simvastatin a...
The purpose of this study was to formulate and characterize bi-layer tablet of doxycycline immediate...
The aim of the work is to develop Bi-layered matrix tablets containing a Biguanide (API I) in SR la...
Objective: The objective of this research was to formulate bi-layer tablet which contains immediate-...
Objective: In the present research work, the aim was to prepare the bilayer tablet of atenolol for b...
Bilayer tablet is new novel of tablet for the successful development of controlled release formulati...
Point of present examination work was attempted to figure bilayer tablets of lornoxicam through its ...